-
Posted by
Two Blokes Jul 6 -
Filed in
Stock
-
7 views
Over the past two years, Iovance Biotherapeutics (IOVA), a small-cap biotech company, has made significant clinical and regulatory progress. However, the stock has also plunged over this period -- shares are currently trading for less than $2 apiece.
